We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Protalix Submits Validation Data on Gaucher’s Drug Candidate
Protalix Submits Validation Data on Gaucher’s Drug Candidate
April 30, 2010
Protalix BioTherapeutics has submitted validation data from an upgraded manufacturing facility for its Gaucher’s disease candidate in response to
an earlier FDA request.